HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

DCC-2701

inhibits c-Met protein, TIE-2 protein, and vascular endothelial growth factor receptor

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aminopyridines: 77
    - DCC-2701: 1
  - Aniline Compounds: 46
    - Anilides: 22
      - DCC-2701: 1
- Amides: 2428
  - Anilides: 22
    - DCC-2701: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Aminopyridines: 77
      - DCC-2701: 1

Experts

1.	Godwin, A K: 1 article (01/2015)
2.	Kaufman, M D: 1 article (01/2015)
3.	Kwon, Y: 1 article (01/2015)
4.	Smith, B D: 1 article (01/2015)
5.	Zhou, Y: 1 article (01/2015)

Related Diseases

1.	Neoplasms (Cancer) 01/08/2015 - "DCC-2701 (Deciphera Pharmaceuticals, LLC), a novel c-MET/TIE-2/VEGFR inhibitor was able to effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. "